LIF inhibits osteoblast differentiation at least in part by regulation of HAS2 and its product hyaluronan

Journal of Bone and Mineral Research

Volumn 22, Issue 8, 2007, Pages 1289-1300

  Falconi, Dominic ^a   Aubin, Jane E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Differential display; Differentiation; Hyaluronan synthase 2; Leukemia inhibitory factor; Osteoblast

Indexed keywords

HYALURONAN SYNTHASE 2; HYALURONIC ACID; HYALURONIDASE; LEUKEMIA INHIBITORY FACTOR; SYNTHETASE; TRANSCRIPTOME; UNCLASSIFIED DRUG; ENZYME INHIBITOR; GLUCURONOSYLTRANSFERASE; HAS2 PROTEIN, RAT; HYALURONOGLUCOSAMINIDASE; LIF PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALVARIA; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; ENZYME REGULATION; FEMALE; FETUS; GENE EXPRESSION; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; SKULL; WISTAR RAT;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCURONOSYLTRANSFERASE; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; LEUKEMIA INHIBITORY FACTOR; MICE; OSTEOBLASTS; RATS; RATS, WISTAR; SKULL;

EID: 34548076623     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.070417     Document Type: Article

References (79)

1. 1 Metcalf D, Gearing DP 1989 Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci USA 86: 5948–5952.
2. 2 Metcalf D, Gearing DP 1989 A myelosclerotic syndrome in mice engrafted with cells producing high levels of leukemia inhibitory factor (LIF). Leukemia 3: 847–852.
3. 3 Liu J, Modrell B, Aruffo A, Marken JS, Taga T, Yasukawa K, Murakami M, Kishimoto T, Shoyab M 1992 Interleukin‐6 signal transducer gp130 mediates oncostatin M signaling. J Biol Chem 267: 16763–16766.
4. 4 Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B, Ziegler SF, Cosman D 1992 The IL‐6 signal transducer, gp130: An oncostatin M receptor and affinity converter for the LIF receptor. Science 255: 1434–1437.
5. 5 Bohic S, Rohanizadeh R, Touchais S, Godard A, Daculsi G, Heymann D 1998 Leukemia inhibitory factor and oncostatin M influence the mineral phases formed in a murine heterotopic calcification model: A Fourier transform‐infrared microspectroscopic study. J Bone Miner Res 13: 1619–1632.
6. 6 Malik N, Haugen HS, Modrell B, Shoyab M, Clegg CH 1995 Developmental abnormalities in mice transgenic for bovine oncostatin M. Mol Cell Biol 15: 2349–2358.
7. 7 Malaval L, Gupta AK, Aubin JE 1995 Leukemia inhibitory factor inhibits osteogenic differentiation in rat calvaria cell cultures. Endocrinology 136: 1411–1418.
8. 8 Malaval L, Liu F, Vernallis AB, Aubin JE 2005 gp130/OSMR is the only LIF/IL‐6 family receptor complex to promote osteoblast differentiation of calvaria progenitors. J Cell Physiol 204: 585–593.
9. 9 Malaval L, Gupta AK, Liu F, Delmas PD, Aubin JE 1998 LIF, but not IL‐6, regulates osteoprogenitor differentiation in rat calvaria cell cultures: Modulation by dexamethasone. J Bone Miner Res 13: 175–184.
10. 10 Malaval L, Aubin JE 2001 Biphasic effects of leukemia inhibitory factor on osteoblastic differentiation. J Cell Biochem 36: 63–70.
11. 11 Bellows CG, Aubin JE, Heersche JN, Antosz ME 1986 Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 38: 143–154.
12. 12 Aubin JE 1999 Osteoprogenitor cell frequency in rat bone marrow stromal populations: Role for heterotypic cell‐cell interactions in osteoblast differentiation. J Cell Biochem 72: 396–410.
13. 13 Liang P, Pardee AB 1992 Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967–971.
14. 14 Liss B 2002 Improved quantitative real‐time RT‐PCR for expression profiling of individual cells. Nucleic Acids Res 30: e89.
15. 15 Lokeshwar VB, Rubinowicz D, Schroeder GL, Forgacs E, Minna JD, Block NL, Nadji M, Lokeshwar BL 2001 Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J Biol Chem 276: 11922–11932.
16. 16 Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, Miyauchi S, Spicer AP, McDonald JA, Kimata K 1999 Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274: 25085–25092.
17. 17 Pilloni A, Bernard GW 1998 The effect of hyaluronan on mouse intramembranous osteogenesis in vitro. Cell Tissue Res 294: 323–333.
18. 18 Huang L, Cheng YY, Koo PL, Lee KM, Qin L, Cheng JC, Kumta SM 2003 The effect of hyaluronan on osteoblast proliferation and differentiation in rat calvarial‐derived cell cultures. J Biomed Mater Res 66A: 880–884.
19. 19 Hattori M, Abraham LJ, Northemann W, Fey GH 1990 Acute‐phase reaction induces a specific complex between hepatic nuclear proteins and the interleukin 6 response element of the rat alpha 2‐macroglobulin gene. Proc Natl Acad Sci USA 87: 2364–2368.
20. 20 Palmqvist L, Glover CH, Hsu L, Lu M, Bossen B, Piret JM, Humphries RK, Helgason CD 2005 Correlation of murine embryonic stem cell gene expression profiles with functional measures of pluripotency. Stem Cells 23: 663–680.
21. 21 Wright LS, Li J, Caldwell MA, Wallace K, Johnson JA, Svendsen CN 2003 Gene expression in human neural stem cells: Effects of leukemia inhibitory factor. J Neurochem 86: 179–195.
22. 22 Topol LZ, Bardot B, Zhang Q, Resau J, Huillard E, Marx M, Calothy G, Blair DG 2000 Biosynthesis, post‐translation modification, and functional characterization of Drm/Gremlin. J Biol Chem 275: 8785–8793.
23. 23 Pereira RC, Economides AN, Canalis E 2000 Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts. Endocrinology 141: 4558–4563.
24. 24 Gazzerro E, Pereira RC, Jorgetti V, Olson S, Economides AN, Canalis E 2005 Skeletal Overexpression of Gremlin Impairs Bone Formation and Causes Osteopenia. Endocrinology 146: 655–665.
25. 25 Michiels L, Van der Rauwelaert E, Van Hasselt F, Kas K, Merregaert J 1993 fau cDNA encodes a ubiquitin‐like‐S30 fusion protein and is expressed as an antisense sequence in the Finkel‐Biskis‐Reilly murine sarcoma virus. Oncogene 8: 2537–2546.
26. 26 Nakamura M, Xavier RM, Tsunematsu T, Tanigawa Y 1995 Molecular cloning and characterization of a cDNA encoding monoclonal nonspecific suppressor factor. Proc Natl Acad Sci USA 92: 3463–3467.
27. 27 Nakamura M, Tanigawa Y 1999 Biochemical analysis of the receptor for ubiquitin‐like polypeptide. J Biol Chem 274: 18026–18032.
28. 28 Nakamura M, Tanigawa Y 2000 Protein tyrosine phosphorylation induced by ubiquitin‐like polypeptide in murine T helper clone type 2. Biochem Biophys Res Commun 274: 565–570.
29. 29 Hughes FJ, Howells GL 1993 Interleukin‐11 inhibits bone formation in vitro. Calcif Tissue Int 53: 362–364.
30. 30 Takeuchi Y, Watanabe S, Ishii G, Takeda S, Nakayama K, Fukumoto S, Kaneta Y, Inoue D, Matsumoto T, Harigaya K, Fujita T 2002 Interleukin‐11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. J Biol Chem 277: 49011–49018.
31. 31 Hahn FM, Xuan JW, Chambers AF, Poulter CD 1996 Human isopentenyl diphosphate: Dimethylallyl diphosphate isomerase: Overproduction, purification, and characterization. Arch Biochem Biophys 332: 30–34.
32. 32 Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G 1999 Stimulation of bone formation in vitro and in rodents by statins. Science 286: 1946–1949.
33. 33 Bauer DC 2003 HMG CoA reductase inhibitors and the skeleton: A comprehensive review. Osteoporos Int 14: 273–282.
34. 34 Seto M, Yamamoto K, Takahashi T, Ueda R 1995 Cloning and expression of a murine cDNA homologous to the human RCK/P54, a lymphoma‐linked chromosomal translocation junction gene on 11q23. Gene 166: 293–296.
35. 35 Akao Y, Marukawa O, Morikawa H, Nakao K, Kamei M, Hachiya T, Tsujimoto Y 1995 The rck/p54 candidate proto‐oncogene product is a 54‐kilodalton D‐E‐A‐D box protein differentially expressed in human and mouse tissues. Cancer Res 55: 3444–3449.
36. 36 Lee CG 2002 RH70, a bidirectional RNA helicase, co‐purifies with U1snRNP. J Biol Chem 277: 39679–39683.
37. 37 Lamm GM, Nicol SM, Fuller‐Pace FV, Lamond AI 1996 p72: A human nuclear DEAD box protein highly related to p68. Nucleic Acids Res 24: 3739–3747.
38. 38 Sabatakos G, Sims NA, Chen J, Aoki K, Kelz MB, Amling M, Bouali Y, Mukhopadhyay K, Ford K, Nestler EJ, Baron R 2000 Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med 6: 985–990.
39. 39 Ameye L, Young MF 2002 Mice deficient in small leucine‐rich proteoglycans: Novel in vivo models for osteoporosis, osteoarthritis, Ehlers‐Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12: 107R–116R.
40. 40 Bengtsson E, Morgelin M, Sasaki T, Timpl R, Heinegard D, Aspberg A 2002 The leucine‐rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor. J Biol Chem 277: 15061–15068.
41. 41 Lewis M 2003 PRELP, collagen, and a theory of Hutchinson‐Gilford progeria. Ageing Res Rev 2: 95–105.
42. 42 Stein GS, Lian JB 1993 Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14: 424–442.
43. 43 Chen XD, Shi S, Xu T, Robey PG, Young MF 2002 Age‐related osteoporosis in biglycan‐deficient mice is related to defects in bone marrow stromal cells. J Bone Miner Res 17: 331–340.
44. 44 Young MF, Bi Y, Ameye L, Chen XD 2002 Biglycan knockout mice: New models for musculoskeletal diseases. Glycoconj J 19: 257–262.
45. 45 Noonan KJ, Stevens JW, Tammi R, Tammi M, Hernandez JA, Midura RJ 1996 Spatial distribution of CD44 and hyaluronan in the proximal tibia of the growing rat. J Orthop Res 14: 573–581.
46. 46 Zhang W, Watson CE, Liu C, Williams KJ, Werth VP 2000 Glucocorticoids induce a near‐total suppression of hyaluronan synthase mRNA in dermal fibroblasts and in osteoblasts: A molecular mechanism contributing to organ atrophy. Biochem J 349: 91–97.
47. 47 Kimoto S, Cheng SL, Zhang SF, Avioli LV 1994 The effect of glucocorticoid on the synthesis of biglycan and decorin in human osteoblasts and bone marrow stromal cells. Endocrinology 135: 2423–2431.
48. 48 Cornish J, Callon K, King A, Edgar S, Reid IR 1993 The effect of leukemia inhibitory factor on bone in vivo. Endocrinology 132: 1359–1366.
49. 49 Recklies AD, White C, Melching L, Roughley PJ 2001 Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem J 354: 17–24.
50. 50 Sampson PM, Rochester CL, Freundlich B, Elias JA 1992 Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine‐regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast‐derived hyaluronidase. J Clin Invest 90: 1492–1503.
51. 51 Ito A, Shimada M, Mori Y 1993 Regulation of hyaluronate production by interleukin 1 in cultured human chorionic cells. Biochim Biophys Acta 1158: 91–97.
52. 52 Kawakami M, Suzuki K, Matsuki Y, Ishizuka T, Hidaka T, Konishi T, Matsumoto M, Kataharada K, Nakamura H 1998 Hyaluronan production in human rheumatoid fibroblastic synovial lining cells is increased by interleukin 1 beta but inhibited by transforming growth factor beta 1. Ann Rheum Dis 57: 602–605.
53. 53 Mohamadzadeh M, DeGrendele H, Arizpe H, Estess P, Siegelman M 1998 Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA‐dependent primary adhesion. J Clin Invest 101: 97–108.
54. 54 Ohkawa T, Ueki N, Taguchi T, Shindo Y, Adachi M, Amuro Y, Hada T, Higashino K 1999 Stimulation of hyaluronan synthesis by tumor necrosis factor‐alpha is mediated by the p50/p65 NF‐kappa B complex in MRC‐5 myofibroblasts. Biochim Biophys Acta 1448: 416–424.
55. 55 Nishida Y, D'Souza AL, Thonar EJ, Knudson W 2000 Stimulation of hyaluronan metabolism by interleukin‐1alpha in human articular cartilage. Arthritis Rheum 43: 1315–1326.
56. 56 Hiscock DR, Caterson B, Flannery CR 2000 Expression of hyaluronan synthases in articular cartilage. Osteoarthritis Cartilage 8: 120–126.
57. 57 Kennedy CI, Diegelmann RF, Haynes JH, Yager DR 2000 Proinflammatory cytokines differentially regulate hyaluronan synthase isoforms in fetal and adult fibroblasts. J Pediatr Surg 35: 874–879.
58. 58 Tanimoto K, Ohno S, Fujimoto K, Honda K, Ijuin C, Tanaka N, Doi T, Nakahara M, Tanne K 2001 Proinflammatory cytokines regulate the gene expression of hyaluronic acid synthetase in cultured rabbit synovial membrane cells. Connect Tissue Res 42: 187–195.
59. 59 Ijuin C, Ohno S, Tanimoto K, Honda K, Tanne K 2001 Regulation of hyaluronan synthase gene expression in human periodontal ligament cells by tumour necrosis factor‐alpha, interleukin‐1beta and interferon‐gamma. Arch Oral Biol 46: 767–772.
60. 60 Oguchi T, Ishiguro N 2004 Differential stimulation of three forms of hyaluronan synthase by TGF‐beta, IL‐1beta, and TNF‐alpha. Connect Tissue Res 45: 197–205.
61. 61 Stuhlmeier KM 2005 Effects of Leflunomide on Hyaluronan Synthases (HAS): NF‐{kappa}B‐Independent Suppression of IL‐1‐Induced HAS1 Transcription by Leflunomide. J Immunol 174: 7376–7382.
62. 62 Uchiyama T, Sakuta T, Kanayama T 2005 Regulation of hyaluronan synthases in mouse uterine cervix. Biochem Biophys Res Commun 327: 927–932.
63. 63 Ellies LG, Aubin JE 1990 Temporal sequence of interleukin 1 alpha‐mediated stimulation and inhibition of bone formation by isolated fetal rat calvaria cells in vitro. Cytokine 2: 430–437.
64. 64 Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J, Nanes MS 2000 Inhibition of osteoblast differentiation by tumor necrosis factor‐alpha. Endocrinology 141: 3956–3964.
65. 65 Yamada Y, Itano N, Zako M, Yoshida M, Lenas P, Niimi A, Ueda M, Kimata K 1998 The gene structure and promoter sequence of mouse hyaluronan synthase 1. Biochem J 330: 1223–1227.
66. 66 Stock AE, Bouchard N, Brown K, Spicer AP, Underhill CB, Dore M, Sirois J 2002 Induction of hyaluronan synthase 2 by human chorionic gonadotropin in mural granulosa cells of equine preovulatory follicles. Endocrinology 143: 4375–4384.
67. 67 Monslow J, Williams JD, Norton N, Guy CA, Price IK, Coleman SL, Williams NM, Buckland PR, Spicer AP, Topley N, Davies M, Bowen T 2003 The human hyaluronan synthase genes: Genomic structures, proximal promoters and polymorphic microsatellite markers. Int J Biochem Cell Biol 35: 1272–1283.
68. 68 Monslow J, Williams JD, Guy CA, Price IK, Craig KJ, Williams HJ, Williams NM, Martin J, Coleman SL, Topley N, Spicer AP, Buckland PR, Davies M, Bowen T 2004 Identification and analysis of the promoter region of the human hyaluronan synthase 2 gene. J Biol Chem 279: 20576–20581.
69. 69 Saavalainen K, Pasonen‐Seppanen S, Dunlop TW, Tammi R, Tammi MI, Carlberg C 2005 The human hyaluronan synthase 2 gene is a primary retinoic acid and epidermal growth factor responding gene. J Biol Chem 280: 14636–14644.
70. 70 Itano N, Kimata K 2002 Mammalian hyaluronan synthases. IUBMB Life 54: 195–199.
71. 71 Jamal HH, Aubin JE 1996 CD44 expression in fetal rat bone: in vivo and in vitro analysis. Exp Cell Res 223: 467–477.
72. 72 Nakamura H, Kenmotsu S, Sakai H, Ozawa H 1995 Localization of CD44, the hyaluronate receptor, on the plasma membrane of osteocytes and osteoclasts in rat tibiae. Cell Tissue Res 280: 225–233.
73. 73 Nakamura H, Ozawa H 1996 Immunolocalization of CD44 and the ERM family in bone cells of mouse tibiae. J Bone Miner Res 11: 1715–1722.
74. 74 Bourguignon LY, Zhu H, Shao L, Chen YW 2001 CD44 interaction with c‐Src kinase promotes cortactin‐mediated cytoskeleton function and hyaluronic acid‐dependent ovarian tumor cell migration. J Biol Chem 276: 7327–7336.
75. 75 Li R, Wong N, Jabali MD, Johnson P 2001 Cd44‐initiated cell spreading induces pyk2 phosphorylation, is mediated by src family kinases, and is negatively regulated by cd45. J Biol Chem 276: 28767–28773.
76. 76 Sohara Y, Ishiguro N, Machida K, Kurata H, Thant AA, Senga T, Matsuda S, Kimata K, Iwata H, Hamaguchi M 2001 Hyaluronan activates cell motility of v‐Src‐transformed cells via Ras‐mitogen‐activated protein kinase and phosphoinositide 3‐kinase‐Akt in a tumor‐specific manner. Mol Biol Cell 12: 1859–1868.
77. 77 Bourguignon LY, Singleton PA, Zhu H, Diedrich F 2003 Hyaluronan‐mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2‐associated binder‐1 phosphorylation and phosphatidylinositol 3‐kinase signaling leading to cytokine (macrophage‐colony stimulating factor) production and breast tumor progression. J Biol Chem 278: 29420–29434.
78. 78 Toole BP 2001 Hyaluronan in morphogenesis. Semin Cell Dev Biol 12: 79–87.
79. 79 Lynch MP, Stein JL, Stein GS, Lian JB 1995 The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: Modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res 216: 35–45.